Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials

CORC > 兰州大学 > 兰州大学 > 基础医学院 > 期刊论文

	Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials
	Zhou, JG; Tian, X; Wang, X; Tian, JH; Wang, Y; Wang, F; Zhang, Y; Ma, H
刊名	MEDICAL ONCOLOGY
	2015-02
卷号	32 期号:2 页码:-
关键词	Non-small cell lung cancer Erlotinib Chemotherapy Meta-analysis
ISSN号	1357-0560
通讯作者	Ma, H (reprint author), Zunyi Med Univ, Affiliated Hosp, Dept Oncol, 149 Dalian Rd, Zunyi 563000, Peoples R China.
学科主题	Oncology
收录类别	SCIE
出版地	TOTOWA
语种	英语
WOS记录号	WOS:000347775900025
内容类型	期刊论文
源URL	[http://ir.lzu.edu.cn/handle/262010/121755]
专题	基础医学院_期刊论文
推荐引用方式 GB/T 7714	Zhou, JG,Tian, X,Wang, X,et al. Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials[J]. MEDICAL ONCOLOGY,2015,32(2):-.
APA	Zhou, JG.,Tian, X.,Wang, X.,Tian, JH.,Wang, Y.,...&Ma, H.(2015).Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials.MEDICAL ONCOLOGY,32(2),-.
MLA	Zhou, JG,et al."Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials".MEDICAL ONCOLOGY 32.2(2015):-.